Terry Smith's position in Catalyst Pharmaceuticals is currently worth $26.5M. That's 0.19% of their equity portfolio (24th largest holding). Terry Smith started to build up the position in Catalyst Pharmaceuticals in Q1 2025 and continued to invest until Q3 2025. Since then they sold 2.52M shares. The stake costed the investor $18.9M, netting the investor a gain of 40% so far.